ACOG — Alpha Cognition Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1655923 ·
Last close
$9.04
Market Cap
$196.87M
52W High
$10.14
52W Low
$4.50
ADV30
110,545
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 6,092,974 | 5,701,917 | -7,756,008 | -8,789,740 | 64,519,883 | 41,384,287 | 11,558,134 |
| Mar 2026 | 3,533,798 | 3,262,022 | -8,096,227 | -6,478,018 | 69,248,341 | 54,248,275 | 11,791,836 |
| Dec 2025 | 2,793,076 | 2,540,827 | -7,925,270 | -6,856,306 | 79,730,235 | 66,046,789 | 17,200,060 |
| Sep 2025 | 2,840,858 | 2,212,797 | -5,301,986 | -1,318,074 | 46,301,213 | 35,398,899 | 12,387,403 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-30,134,079
Investing CF
$-231,541
Financing CF
$39,050,066
CapEx
$-231,541
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.38
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-103,584,793
Inventory
$6,043,714
Receivables
$3,752,090
ST Investments
—
EBIT TTM
$-27,060,484
Pretax Income TTM
$-25,141,350
Interest Exp TTM
$34,094
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$15,260,706
EBITDA
$-26,487,652
Free Cash Flow
$-28,530,086
Enterprise Value
$152,438,800
Total Cash
$41,384,288
Total Debt
$0
Shares Out
21,777,868
Trailing EPS
$-0.96
Book Value
$2.43
ROE
-49.5%
ROA
-30.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 10,220,275 | -22,579,594 | -20,669,875 | 79,730,235 | 17,200,060 | 62,530,175 | -20,380,367 |
| Dec 2024 | 0 | -11,548,636 | -14,788,727 | 50,736,938 | 11,642,111 | 39,094,827 | -7,755,654 |
| Dec 2023 | 0 | -9,617,813 | -13,763,658 | 2,452,170 | 7,155,865 | -4,703,695 | -8,799,565 |
| Dec 2022 | 0 | -13,465,624 | -12,114,698 | 2,950,951 | 4,271,128 | -1,320,177 | -9,241,650 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$10,825,419
NetIncome TTM
$-25,141,350
OpCashFlow TTM
—
Assets (Latest)
$69,248,341
Forward EPS
$-0.62
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.50 · spot: $9.16 · call volume: 50 · put volume: 1
Expected Move to 2026-10-16:
±$3.60
(39.30%) —
implied range
$5.56 –
$12.76
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CGEN | COMPUGEN LTD | $200.82M | $2.12 | — |
| IVVD | Invivyd, Inc. | $206.45M | $0.70 | — |
| PLX | Protalix BioTherapeutics, Inc. | $217.54M | $2.70 | — |
| DTIL | PRECISION BIOSCIENCES INC | $177.48M | $6.43 | — |
| CMPX | Compass Therapeutics, Inc. | $177.10M | $0.98 | — |
News headlines (Yahoo Finance, 1h cache)
Alpha Cognition to Present New ZUNVEYL® (Benzgalantamine) Clinical and Real-World Data at ASCP Annual Meeting and NEI Fall Congress
2026-10-06 12:30 · Yahoo
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-10-02 23:06 · Yahoo
Alpha Cognition Announces CONVERGE Real-World Evidence on ZUNVEYL®(Benzgalantamine) Use in Long-Term Care
2026-10-01 12:30 · Yahoo
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26
2026-08-17 14:43 · Yahoo
Alpha Cognition (ACOG) Stock Fair Value Rises After Zunveyl Analyst Optimism
2026-08-17 12:09 · Yahoo
Alpha Cognition (ACOG) Q2 2026 Earnings Call Transcript
2026-08-14 02:59 · Yahoo
Alpha Cognition Q2 Earnings Call Highlights
2026-08-13 22:04 · Yahoo
Alpha Cognition Inc. (ACOG) Reports Q2 Loss, Tops Revenue Estimates
2026-08-13 21:15 · Yahoo
Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update
2026-08-03 12:30 · Yahoo
Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease
2026-07-29 12:30 · Yahoo
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-10-02 16:05:22 | 2026-10-01 | Opaleye Management Inc. | 10% | P - Purchase | 8.69 | 19050 | 165634 |